Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 771,743 | 422,729 | 430,708 | 481,147 | 340,450 |
| Marketable Securities | 62,447 | N/A | N/A | N/A | N/A |
| Receivables | 4,951 | N/A | N/A | N/A | N/A |
| TOTAL | $863,413 | $437,874 | $445,352 | $487,822 | $346,791 |
| Non-Current Assets | |||||
| PPE Net | 242 | 231 | 234 | 101 | 46 |
| Intangibles | 534 | 593 | 542 | 486 | 170 |
| Other Non-Current Assets | 431 | 493 | 562 | 54 | 90 |
| TOTAL | $1,207 | $1,317 | $1,338 | $641 | $306 |
| Total Assets | $864,620 | $439,191 | $446,690 | $488,463 | $347,097 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,744 | 7,039 | 5,275 | 8,536 | 16,923 |
| Accrued Expenses | 13,608 | 10,580 | 10,194 | 9,970 | 11,398 |
| Other current liabilities | 82,312 | 18,901 | 23,545 | 33,061 | 12,574 |
| TOTAL | $106,918 | $41,255 | $45,307 | $59,726 | $49,897 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,008 | 4,495 | 6,059 | 8,116 | 8,942 |
| Other Non-Current Liabilities | 202 | 19,074 | 13,722 | 16,490 | 7,788 |
| TOTAL | $202 | $19,074 | $13,944 | $16,934 | $8,807 |
| Total Liabilities | $107,120 | $60,329 | $59,251 | $76,660 | $58,704 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 109,818 | 92,386 | 90,015 | 89,977 | N/A |
| Common Shares | 13,444 | 11,435 | 11,151 | 11,113 | 10,173 |
| Retained earnings | -558,571 | -466,394 | -449,747 | -410,740 | -316,973 |
| Other shareholders' equity | 4,467 | 4,422 | 4,422 | 4,422 | 4,422 |
| TOTAL | $757,500 | $378,862 | $387,439 | $411,803 | $288,393 |
| Total Liabilities And Equity | $864,620 | $439,191 | $446,690 | $488,463 | $347,097 |